Testing effectiveness (Phase 2)UnknownNCT03363555
What this trial is testing
SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma
Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Jiangsu HengRui Medicine Co., Ltd. 97